A carregar...
Nanomedicines in the treatment of emesis during chemotherapy: focus on aprepitant
Aprepitant, a selective high-affinity antagonist of human substance P/neurokinin 1 (NK(1)) receptors, is the active ingredient of EMEND(®) which has recently been approved by the FDA for the prevention of chemotherapy-induced nausea and vomiting (CINV). Aprepitant undergoes extensive metabolism, pri...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2007
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2673828/ https://ncbi.nlm.nih.gov/pubmed/17722507 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|